Literature DB >> 28831839

Customized Versus Noncustomized Sound Therapy for Treatment of Tinnitus: A Randomized Crossover Clinical Trial.

Hossein Mahboubi1, Yarah M Haidar1, Saman Kiumehr1, Kasra Ziai1, Hamid R Djalilian1,2.   

Abstract

OBJECTIVES: To determine the effectiveness of a customized sound therapy and compare its effectiveness to that of masking with broadband noise.
METHODS: Subjects were randomized to receive either customized sound therapy or broadband noise for 2 hours per day for 3 months and then switched to the other treatment after a washout period. The outcome variables were tinnitus loudness (scored 0-10), Tinnitus Handicap Inventory (THI), Beck Anxiety Inventory (BAI), minimum masking levels (MML), and residual inhibition (RI).
RESULTS: Eighteen subjects completed the study. Mean age was 53 ± 11 years, and mean tinnitus duration was 118 ± 99 months. With customized sound therapy, mean loudness decreased from 6.4 ± 2.0 to 4.9 ± 1.9 ( P = .001), mean THI decreased from 42.8 ± 21.6 to 31.5 ± 20.3 ( P < .001), mean BAI decreased from 10.6 ± 10.9 to 8.3 ± 9.9 ( P = .01), and MML decreased from 22.3 ± 11.6 dB SL to 17.2 ± 10.6 dB SL ( P = .005). After 3 months of broadband noise therapy, only BAI and, to a lesser degree, MML decreased ( P = .003 and .04, respectively).
CONCLUSIONS: Customized sound therapy can decrease the loudness and THI scores of tinnitus patients, and the results may be superior to broadband noise.

Entities:  

Keywords:  clinical trial; customized sound therapy; masking; minimum masking level; residual inhibition; sound therapy; tinnitus; tinnitus handicap inventory

Mesh:

Year:  2017        PMID: 28831839     DOI: 10.1177/0003489417725093

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  8 in total

1.  COVID-19 associated anxiety enhances tinnitus.

Authors:  Li Xia; Gang He; Yong Feng; Xiaoxu Yu; Xiaolong Zhao; Shankai Yin; Zhengnong Chen; Jian Wang; Jiangang Fan; Chuan Dong
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

2.  Individual Reliability of the Standard Clinical Method vs Patient-Centered Tinnitus Likeness Rating for Assessment of Tinnitus Pitch and Loudness Matching.

Authors:  Sylvie Hébert
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

3.  A Prospective Study of the Effect of Tinnitus Sound Matching Degree on the Efficacy of Customized Sound Therapy in Patients with Chronic Tinnitus.

Authors:  JinYu Wang; Juan Ding; Jing Song; Li Hu; Ning Cong; Zhao Han
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2021-09-03       Impact factor: 1.919

Review 4.  S3 Guideline: Chronic Tinnitus : German Society for Otorhinolaryngology, Head and Neck Surgery e. V. (DGHNO-KHC).

Authors:  Birgit Mazurek; Gerhard Hesse; Heribert Sattel; Volker Kratzsch; Claas Lahmann; Christian Dobel
Journal:  HNO       Date:  2022-10-13       Impact factor: 1.330

Review 5.  The state of the art of sound therapy for subjective tinnitus in adults.

Authors:  Haiyan Wang; Dongmei Tang; Yongzhen Wu; Li Zhou; Shan Sun
Journal:  Ther Adv Chronic Dis       Date:  2020-09-14       Impact factor: 5.091

6.  Adapting Personal Therapies Using a Mobile Application for Tinnitus Rehabilitation: A Preliminary Study.

Authors:  Mehdi Abouzari; Khodayar Goshtasbi; Brooke Sarna; Yaser Ghavami; Erica M Parker; Pooya Khosravi; Navid Mostaghni; Shahrnaz Jamshidi; Tina Saber; Hamid R Djalilian
Journal:  Ann Otol Rhinol Laryngol       Date:  2020-10-08       Impact factor: 1.973

Review 7.  The Pathological Mechanisms and Treatments of Tinnitus.

Authors:  Sana Saeed; Qudsia Umaira Khan
Journal:  Discoveries (Craiova)       Date:  2021-09-30

8.  Distinct brain structural-functional network topological coupling explains different outcomes in tinnitus patients treated with sound therapy.

Authors:  Qian Chen; Han Lv; Zhaodi Wang; Xuan Wei; Jiao Liu; Fang Liu; Pengfei Zhao; Zhenghan Yang; Shusheng Gong; Zhenchang Wang
Journal:  Hum Brain Mapp       Date:  2022-03-25       Impact factor: 5.399

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.